The COMPASSION Study
Recruiting · NCT06507930 · Interventional (participants receive a specific treatment) · Lead sponsor: Dana-Farber Cancer Institute
View the official record on ClinicalTrials.gov →Interventions studied
Telehealth Hospice Visits
What this trial is about
The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patient of any gender with unresectable locally advanced or metastatic breast cancer
- Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment
- Ability to conduct video or phone check-ins, even if assistance required.
- Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
- Hospice setting is within Massachusetts
- Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team
- Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment
Exclusion criteria
- Unable to provide verbal consent
- Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
- Hospice setting outside of Massachusetts
- Individuals who are under the age of 18, as this is not a project focused on pediatric patients.
Where it is running
1 location listed across 1 US state.
- Dana-Farber Cancer Institute - Boston, Massachusetts, United States